Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
10526 studies found for:    Communicable Diseases: Clinical Trials
Show Display Options
Rank Status Study
1 Completed Effect of Active vs. Passive Voiding Trials on Time to Discharge, Urinary Tract Infection, and Urinary Retention
Conditions: Urinary Retention;   Urinary Tract Infections
Interventions: Procedure: Active Voiding Trial;   Procedure: Passive Voiding Trial
2 Active, not recruiting Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials
Conditions: Aids-related Malignancies;   Lymphoma;   Precancerous Condition;   Sarcoma
Interventions: Genetic: polymerase chain reaction;   Other: cytology specimen collection procedure;   Other: histological technique;   Procedure: colposcopic biopsy
3 Withdrawn Immune Response to Hepatitis C Virus
Conditions: Hepatitis C;   HIV Infections
Intervention: Other: None. Not a clinical trial. Specimens taken for basic research in laboratory.
4 Completed Prevention of Nosocomial Infection by Decontamination of the Naso- and Oropharynx With Chlorhexidine (NONI Trial)
Conditions: Nosocomial Infection;   Respiratory Tract Infection;   Surgical Site Infection
Intervention: Drug: Chlorhexidine gluconate (drug) vs placebo
5 Recruiting Cranberry Extract and Urinary Infection Prevention: a Clinical Trial
Condition: Urinary Tract Infections
Intervention: Dietary Supplement: Cranberry extract
6 Terminated Efficacy Study of Antimicrobial Catheters to Avoid Urinary Infections in Spinal Cord Injured Patients
Condition: Urinary Tract Infection
Interventions: Device: Silver Alloy-Coated Urinary Catheters;   Device: Conventional Urinary Catheter
7 Completed Randomised Controlled Clinical Trials of the Effect of Therapeutic Hookworm Infection in Allergic Rhinoconjunctivitis
Conditions: Rhinitis, Allergic, Perennial;   Hayfever;   Allergy
Intervention: Procedure: Infection with hookworm larvae
8 Completed A Randomized Clinical Trial to Prevent Recurrent CA-MRSA Infection
Condition: Methicillin Resistant Staphylococcus Aureus Skin Infections
Interventions: Drug: mupirocin and chlorhexidine;   Behavioral: household cleaning and disinfection;   Drug: mupirocin, chlorhexidine, & household cleaning/disinfection
9 Completed Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
Condition: Recurrent C. Difficile Infection.
Interventions: Other: Fecal Microbiota Transplantation;   Drug: Standard Antibiotic Therapy;   Drug: Vancomycin (before randomization)
10 Completed Peer-Driven Intervention to Enroll Minorities/Women in HIV/AIDS Clinical Trials (the ACT2 Project)
Condition: HIV Infections
Interventions: Behavioral: Peer-driven intervention;   Behavioral: Time-matched health education
11 Recruiting The Amputation Surgical Site Infection Trial (ASSIT)
Conditions: Wound Infection;   Amputation Wound
Interventions: Drug: Co-amoxiclav;   Drug: Iodine;   Drug: Metronidazole;   Drug: Chlorhexidine;   Drug: Teicoplanin;   Drug: Clindamycin
12 Unknown  CATCH - Catheter Infections in Children
Condition: Catheter-Related Infections
Interventions: Device: Standard polyurethane Central Venous Catheter;   Device: Antibiotic impregnated polyurethane CVC (minocycline and rifampicin);   Device: Heparin bonded polyurethane CVC
13 Completed Long-Term Data Collection From Participants in Adult AIDS Clinical Trials
Condition: HIV Infections
14 Completed Trial of Positive Deviance in Inpatient Wards to Reduce Hospital Infections
Condition: Healthcare-associated Infections
Interventions: Behavioral: Positive Deviance;   Other: Standard-of-Care Infection Control approach
15 Completed A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
Condition: HIV Infections
Intervention: Other: Observation
16 Recruiting Preoperative Decolonization and Surgical Site Infections - a Prospective Randomized Trial
Conditions: Orthopedic Disorders;   Surgical Site Infection
Interventions: Drug: Mupirocin 2% nasal ointement;   Drug: Chlorhexidine sol 4%
17 Active, not recruiting Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants
Condition: Cytomegalovirus Infections
Intervention: Biological: CMV-Peptide-Specific T cells
18 Active, not recruiting Phase 1 Clinical Trial With Controlled Human Malaria Infection (CHMI) to Evaluate the Safety and Efficacy of the Plasmodium Falciparum Vaccine Candidate FMP012 Administered Intramuscularly With AS01B Adjuvant System in Healthy Malaria-Naïve Adults
Condition: Malaria
Interventions: Biological: FMP012 with AS01B adjuvant system;   Other: P falciparum Controlled Human Malaria Infection (CHMI)
19 Completed Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection
Conditions: HIV Infections;   Gonorrhea;   Chlamydial Infections;   Genital Herpes
Interventions: Drug: PRO 2000/5;   Drug: Placebo
20 Completed Once a Day (QD) - Twice a Day (BID) Clinical Trial: Didanosine, Lamivudine and Efavirenz Versus Zidovudine, Lamivudine and Efavirenz in the Starting Treatment of HIV
Condition: HIV Infections
Intervention: Drug: didanosine + lamivudine + efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years